Cwestiwn ysgrifenedig WQ97126
- Gofynnwyd gan
- Julie MorganLlafur
- I'w ateb gan
- Cabinet Secretary for Health and Social Care
- Cyflwynwyd
- Dyddiad ateb
- Atebwyd
- Amser i'w ateb
- 6 diwrnod
Cwestiwn
Mae'r cwestiwn a'r ateb yn Saesneg gan nad oes fersiwn Gymraeg ar gael.
What are the new treatments available under the new treatment fund by year in this Senedd term?
Ateb
Atebwyd gan Cabinet Secretary for Health and Social Care
In the period April 2021 to March 2025, 343 treatments have been made available through the New Treatment Fund.
Since April 2023, all details of medicines supported by the New Treatment Fund have been published by the All Wales Therapeutics and Toxicology Centre (AWTTC) and can be accessed at: The New Treatment Fund - All Wales Therapeutics and Toxicology Centre.
Treatments approved in 2021 and 2022 and the details of some medicines which have been approved since April 2025, are not included in the data published via the link above.
The medicines added to the New Treatment Fund between 2021 and 2023 (prior to the ATTWC publication link) are as follows:
Period: 2021-22
Treatment
Indication
Abemaciclib
Breast cancer
Adalimumab
Rheumatoid arthritis
Adalimumab
Ulcerative colitis
Amikacin liposomal
Nontuberculous mycobacterial (NTM) lung infections
Apalutamide
Metastatic prostate cancer
Apalutamide
Non-metastatic prostate cancer
Atezolizumab
Lung cancer
Atezolizumab
Urothelial cancer
Atidarsagene autotemcel
Metachromatic leukodystrophy
Avelumab
Urothelial cancer
Azacitidine
Leukaemia
Belimumab
Systemic lupus erythematosus
Bempedoic acid
Primary hypercholesterolaemia or mixed dyslipidaemia
Bempedoic acid-ezetimibe
Primary hypercholesterolaemia or mixed dyslipidaemia
Berotralstat
Hereditary angioedema
Bimekizumab
Psoriasis
Bortezomib
Multiple myeloma